Aurobindo Pharma Q1 Results

  • BSE: 524804
  • NSE: AUROPHARMA
  • ISIN: INE406A01037
  • Sector: Major Drugs
BSE
1,236.3512.70 (1.04%)
Volume10.45 K
Updated: Mon 25 Nov, 2024 | 15:29:42
NSE
1,241.7518.05 (1.48%)
Volume1.76 M
Updated: Mon 25 Nov, 2024 | 15:31:16
Today: 1,232.90
1,255.90
52-Wk: 959.05
1,592.55

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Aurobindo Pharma Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 24Mar 23QoQ CompJun 23YoY Comp
    Total Revenue 7,567.026,472.96-%6,850.52-%
    Selling/ General/ Admin Expenses Total 1,071.95851.90-%951.97-%
    Depreciation/ Amortization 404.18345.57-%326.56-%
    Other Operating Expenses Total 1,802.821,727.49-%1,592.47-%
    Total Operating Expense 6,351.635,855.93-%6,095.46-%
    Operating Income 1,215.39617.03-%755.06-%
    Net Income Before Taxes 1,323.89730.06-%812.03-%
    Net Income 919.22506.27-%570.75-%
    Diluted Normalized EPS 15.698.64-%10.58-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts